At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> Corporate Governance >> Insider Transactions

Insider Transactions

Date Name Title Type Sorted Descending Shares Traded Price Range
Jul 27, 2007 fhm iv lp Beneficial Owner (10% or more) Buy 17,800 11.26 - 11.50
Jul 25, 2007 fhm iv lp Beneficial Owner (10% or more) Buy 29,700 11.35 - 11.50
Jul 26, 2007 fhm iv lp Beneficial Owner (10% or more) Buy 3,896 11.19 - 11.42
Jul 26, 2007 fhm iv lp Beneficial Owner (10% or more) Buy 4,104 11.44 - 11.50
Jun 28, 2007 fhm iv lp Beneficial Owner (10% or more) Buy 4,281 11.48 - 11.50
Jun 29, 2007 fhm iv lp Beneficial Owner (10% or more) Buy 13,900 11.41 - 11.50
Jul 17, 2012 glaxosmithkline plc Beneficial Owner (10% or more) Buy 2,949,581 6.30
Mar 7, 2012 kramlich c richard Beneficial Owner (10% or more) Buy 1,140,000 5.70
Mar 7, 2012 new enterprise associates 11 lp Beneficial Owner (10% or more) Buy 925,154 5.70
Mar 7, 2012 newhall charles w iii Beneficial Owner (10% or more) Buy 1,140,000 5.70
Mar 7, 2012 perry mark w Beneficial Owner (10% or more) Buy 1,140,000 5.70
Aug 24, 2007 sblendorio glenn Director Buy 1,000 11.39 - 11.44
Jul 27, 2007 topper james n Director Buy 17,800 11.26 - 11.50
Aug 8, 2007 topper james n Director Buy 29,600 11.50
Jul 26, 2007 topper james n Director Buy 4,104 11.44 - 11.50
Jul 25, 2007 topper james n Director Buy 29,700 11.35 - 11.50
Jul 26, 2007 topper james n Director Buy 3,896 11.19 - 11.42
Jun 27, 2007 topper james n Director Buy 91,612 11.11 - 11.50
Jun 27, 2007 topper james n Director Buy 52,788 10.95 - 11.23
Jun 28, 2007 topper james n Director Buy 4,734 11.32 - 11.47
Showing 141-160 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.


Copyright © 2012 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy